Fidelity Investments
STTK icon

Fidelity Investments’s Shattuck Labs STTK Stock Holding History

Fidelity Investments’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.52M Sell
392,500
-100
-0% -$474 ﹤0.01% 2561
2025
Q4 		$1.43M Buy
392,600
+389,233
+11,560% +$929K ﹤0.01% 2717
2025
Q3 		$8.05K Sell
3,367
-5,071
-60% -$6.21K ﹤0.01% 4669
2025
Q2 		$6.68K Sell
8,438
-1,778
-17% -$1.72K ﹤0.01% 4637
2025
Q1 		$9.71K Buy
10,216
+3,937
+63% +$4.85K ﹤0.01% 4511
2024
Q4 		$7.6K Sell
6,279
-7,152,811
-100% -$8.86M ﹤0.01% 4549
2024
Q3 		$25M Buy
7,159,090
+26,460
+0.4% +$98.6K ﹤0.01% 1634
2024
Q2 		$27.5M Buy
7,132,630
+11,483
+0.2% +$93.4K ﹤0.01% 1537
2024
Q1 		$63.7M Buy
7,121,147
+49,973
+0.7% +$458K ﹤0.01% 1228
2023
Q4 		$50.4M Buy
7,071,174
+736,894
+12% +$2.01M ﹤0.01% 1287
2023
Q3 		$9.63M Sell
6,334,280
-36,413
-0.6% -$83.1K ﹤0.01% 1836
2023
Q2 		$19.9M Buy
6,370,693
+3,330
+0.1% +$9.66K ﹤0.01% 1636
2023
Q1 		$18.7M Buy
6,367,363
+8,776
+0.1% +$31K ﹤0.01% 1631
2022
Q4 		$14.6M Buy
6,358,587
+1,286
+0% +$3.22K ﹤0.01% 1745
2022
Q3 		$17.2M Buy
6,357,301
+409
+0% +$1.53K ﹤0.01% 1663
2022
Q2 		$25.8M Buy
6,356,892
+2,360
+0% +$8.54K ﹤0.01% 1552
2022
Q1 		$27.1M Buy
6,354,532
+17,552
+0.3% +$99.5K ﹤0.01% 1649
2021
Q4 		$53.9M Buy
6,336,980
+18,564
+0.3% +$256K ﹤0.01% 1398
2021
Q3 		$129M Buy
6,318,416
+32,549
+0.5% +$696K 0.01% 994
2021
Q2 		$182M Buy
6,285,867
+19,503
+0.3% +$570K 0.01% 865
2021
Q1 		$183M Buy
6,266,364
+4,729
+0.1% +$199K 0.02% 824
2020
Q4 		$317M Buy
+6,261,635
New +$201M 0.03% 558

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Fidelity Investments's STTK Position: Q1 2026 in Review

Fidelity Investments reduced its Shattuck Labs (STTK) stake by 0.03% in Q1 2026, selling an estimated $474 and leaving 392,500 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2561.

Fidelity Investments first reported a position in STTK in Q4 2020 and has held it in 22 quarters since. The position peaked at $317M in Q4 2020. 84 funds tracked by Wall St. Rank hold STTK as of Q1 2026.

  • Fidelity Investments held 392,500 shares of Shattuck Labs worth $2.52M as of Q1 2026.
  • Fidelity Investments sold 100 Shattuck Labs shares in Q1 2026, an estimated $474.
  • Shattuck Labs made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2561 holding.
  • Fidelity Investments first reported a position in Shattuck Labs in Q4 2020 and has held it in 22 quarters since.
  • Fidelity Investments's Shattuck Labs position peaked at $317M in Q4 2020.
  • 84 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.